Follow
Sophie Farrow
Sophie Farrow
Liggins Institute
Verified email at aucklanduni.ac.nz
Title
Cited by
Cited by
Year
Common Variants Coregulate Expression of GBA and Modifier Genes to Delay Parkinson's Disease Onset
W Schierding, S Farrow, T Fadason, OEE Graham, TL Pitcher, S Qubisi, ...
Movement Disorders 35 (8), 1346-1356, 2020
372020
Assigning function to SNPs: considerations when interpreting genetic variation
T Fadason, S Farrow, S Gokuladhas, E Golovina, D Nyaga, JM O’Sullivan, ...
Seminars in Cell & Developmental Biology 121, 135-142, 2022
322022
Establishing gene regulatory networks from Parkinson’s disease risk loci
SL Farrow, W Schierding, S Gokuladhas, E Golovina, T Fadason, ...
Brain 145 (7), 2422-2435, 2022
272022
Redefining the hypotheses driving Parkinson’s diseases research
SL Farrow, AA Cooper, JM O’Sullivan
NPJ Parkinson's disease 8 (1), 45, 2022
202022
A transcription regulatory network within the ACE2 locus may promote a pro-viral environment for SARS-CoV-2 by modulating expression of host factors
T Fadason, S Gokuladhas, E Golovina, D Ho, S Farrow, D Nyaga, H Pan, ...
bioRxiv, 2020.04. 14.042002, 2020
142020
Machine learning identifies six genetic variants and alterations in the heart atrial appendage as key contributors to PD risk predictivity
D Ho, W Schierding, SL Farrow, AA Cooper, AW Kempa-Liehr, ...
Frontiers in genetics 12, 785436, 2022
92022
Discovering genetic mechanisms underlying the co-occurrence of Parkinson’s disease and non-motor traits
S Gokuladhas, T Fadason, S Farrow, A Cooper, JM O’Sullivan
npj Parkinson's Disease 10 (1), 27, 2024
42024
Genetic variants associated with alcohol dependence co-ordinate regulation of ADH genes in gastrointestinal and adipose tissues
R Hibberd, E Golovina, S Farrow, JM O’Sullivan
Scientific Reports 10 (1), 9897, 2020
42020
Identification of 27 allele-specific regulatory variants in Parkinson’s disease using a massively parallel reporter assay
SL Farrow, S Gokuladhas, W Schierding, M Pudjihartono, JK Perry, ...
npj Parkinson's Disease 10 (1), 44, 2024
32024
Benchmarking and quality control for nanopore sequencing and feasibility of rapid genomics in New Zealand: validation phase at a single quaternary hospital
DM Nyaga, P Tsai, C Gebbie, HH Phua, P Yap, PLQ Stabej, S Farrow, ...
medRxiv, 2024.06. 13.24307636, 2024
12024
From blood vessels to brain cells: Connecting the circulatory system and Parkinson's disease
OJ Olaoye, SL Farrow, DM Nyaga, AA Cooper, JM O’Sullivan
Journal of Parkinson’s Disease, 1877718X241308168, 2025
2025
Benchmarking nanopore sequencing and rapid genomics feasibility: validation at a quaternary hospital in New Zealand
DM Nyaga, P Tsai, C Gebbie, HH Phua, P Yap, P Le Quesne Stabej, ...
NPJ Genomic Medicine 9 (1), 57, 2024
2024
Fine-mapping identifies 27 allele-specific MPRA regulatory variants in Parkinson’s disease related loci
S Farrow, S Gokuladhas, W Schierding, M Pudjihartono, J Perry, ...
2023
Identifying the genetic links between Parkinson’s disease and non-motor symptoms: novel insights into disease mechanisms
J O'Sullivan, S Gokuladhas, T Fadason, S Farrow, A Cooper
2023
Correction to: Establishing gene regulatory networks from Parkinson’s disease risk loci
SL Farrow, W Schierding, S Gokuladhas, E Golovina, T Fadason, ...
Brain 146 (e94), e94, 2023
2023
Integrating Multimorbidity into a Whole-Body Understanding of Disease Using Spatial Genomics
S Gokuladhas, RE Zaied, W Schierding, S Farrow, T Fadason, ...
Nuclear, Chromosomal, and Genomic Architecture in Biology and Medicine, 157-187, 2022
2022
Redefining an Idiopathic Disease: The three-dimensional genome in Parkinson's disease (s)
SL Farrow
PhD Thesis-University of Auckland, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–17